Olga Kubassova, PhD[email protected]Nuclear MedicineHow medical imaging can accelerate drug developmentIt can take 15 years to get a drug candidate from the lab to approval. Could medical imaging speed up that process? Olga Kubassova, PhD, of Image Analysis Group explains how imaging modalities such as MRI, CT, and PET are helping to track biomarkers in clinical studies, potentially bringing lifesaving therapies to patients more quickly.January 21, 2019Page 1 of 1Top StoriesISMRM 2024ISMRM: Advanced MRI techniques shed new light in multiple sclerosisSINGAPORE – Quantitative MRI techniques offer valuable insights into diverse pathological processes underlying multiple sclerosis (MS), with these techniques poised for clinical use, according to a leading expert.ISMRM 2024ISMRM: Does MRI have a role in the emergency department?ISMRM 2024ISMRM: AI model could reduce contrast agents in cardiac MRIISMRM 2024ISMRM: Tracking muscle fat with MRI could help reduce functional declineSponsor ContentIMV’s Oncology in Diagnostic Imaging Market Outlook Report